92 related articles for article (PubMed ID: 7870765)
1. Photoactive terthiophenes: the influence of serum on anti-HIV (human immunodeficiency virus) activities.
Hudson JB; Marles RJ; Soucy-Breau C; Harris L; Arnason JT
Photochem Photobiol; 1994 Dec; 60(6):591-3. PubMed ID: 7870765
[TBL] [Abstract][Full Text] [Related]
2. The anti-HIV activities of photoactive terthiophenes.
Hudson JB; Harris L; Marles RJ; Arnason JT
Photochem Photobiol; 1993 Aug; 58(2):246-50. PubMed ID: 8415917
[TBL] [Abstract][Full Text] [Related]
3. The anti-HIV activity of the phytochemical alpha-terthienyl.
Hudson JB; Harris L; Teeple A; Towers GH
Antiviral Res; 1993 Jan; 20(1):33-43. PubMed ID: 8457146
[TBL] [Abstract][Full Text] [Related]
4. Light-mediated activities of thiarubrines against human immunodeficiency virus.
Hudson JB; Balza F; Harris L; Towers GH
Photochem Photobiol; 1993 Apr; 57(4):675-80. PubMed ID: 8389484
[TBL] [Abstract][Full Text] [Related]
5. Photoinactivation of virus infectivity by hypocrellin A.
Hirayama J; Ikebuchi K; Abe H; Kwon KW; Ohnishi Y; Horiuchi M; Shinagawa M; Ikuta K; Kamo N; Sekiguchi S
Photochem Photobiol; 1997 Nov; 66(5):697-700. PubMed ID: 9383993
[TBL] [Abstract][Full Text] [Related]
6. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
[TBL] [Abstract][Full Text] [Related]
7. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.
Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636
[TBL] [Abstract][Full Text] [Related]
9. [Experimental use of a variant of the human immunodeficiency virus (HIV-1) with decreased sensitivity to 3'-azido-2',3'-dideoxythymidine and a study of its properties].
Selimova LM; Galegov GA
Dokl Akad Nauk; 1995 Oct; 344(4):562-4. PubMed ID: 8590871
[No Abstract] [Full Text] [Related]
10. Structure-activity studies of photoactivated antiviral and cytotoxic tricyclic thiophenes.
Marles RJ; Hudson JB; Graham EA; Soucy-Breau C; Morand P; Compadre RL; Compadre CM; Towers GH; Arnason JT
Photochem Photobiol; 1992 Oct; 56(4):479-87. PubMed ID: 1333615
[TBL] [Abstract][Full Text] [Related]
11. Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase.
Humber DC; Cammack N; Coates JA; Cobley KN; Orr DC; Storer R; Weingarten GG; Weir MP
J Med Chem; 1992 Aug; 35(16):3080-1. PubMed ID: 1501235
[No Abstract] [Full Text] [Related]
12. Teleocidins and benzolactams inhibit cell killing by human immunodeficiency virus type 1 (HIV-1).
Endo Y; Ohno M; Hirano M; Fujiwara T; Sato A; Hinuma Y; Shudo K
Biol Pharm Bull; 1994 Aug; 17(8):1147-9. PubMed ID: 7820129
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of some 2,2':5',2"-terthiophene derivatives.
Mares D; Romagnoli C; Rossi R; Carpita A; Ciofalo M; Bruni A
Mycoses; 1994; 37(9-10):377-83. PubMed ID: 7746300
[TBL] [Abstract][Full Text] [Related]
14. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.
Balzarini J; Pelemans H; Aquaro S; Perno CF; Witvrouw M; Schols D; De Clercq E; Karlsson A
Mol Pharmacol; 1996 Aug; 50(2):394-401. PubMed ID: 8700148
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV-1 activity of N-hydroxy-N1-aminoguanidines.
Doubell PC; Oliver DW
Arzneimittelforschung; 1992 Jan; 42(1):65-9. PubMed ID: 1586383
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.
Inouye Y; Tokutake Y; Kunihara J; Yoshida T; Yamase T; Nakata A; Nakamura S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):805-7. PubMed ID: 1377101
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of the crude extract from a seaweed of Dygenea simplex C. Agardh on the in vitro cytopathic activity of HIV-1 and it's antigen production.
Sekine H; Ohonuki N; Sadamasu K; Monma K; Kudoh Y; Nakamura H; Okada Y; Okuyama T
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1580-4. PubMed ID: 7586085
[TBL] [Abstract][Full Text] [Related]
18. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
Fujihashi T; Sakata T; Kaji A; Kaji H
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of terthiophenes and polyynes from the Asteraceae.
Hudson JB; Graham EA; Rossi R; Carpita A; Neri D; Towers GH
Planta Med; 1993 Oct; 59(5):447-50. PubMed ID: 8255937
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.
Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN
J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
